Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Yajima

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Shock (Augusta, Ga.)|May 8, 2007
Inhibition of neutrophil elastase attenuates gut mucosal injury evoked by acute alveolar hypoxia in rabbitsNorihito Nakamura, Hiroshi Morisaki, Takeshi Suzuki, et al.
The American Journal of Case Reports|July 13, 2024
A Rare Case of Ileocecal Lymph Node Recurrence After Surgery in Siewert's Classification Type I Esophagogastric Junction AdenocarcinomaTakaatsu Bessho, Yasuyuki Miura, Satoshi Yajima, et al.
Surgery Today|November 19, 2013
Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a caseHideaki Shimada, Matsuo Nagata, Akihiro Cho, et al.
Molecular and Clinical Oncology|October 15, 2021
Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancersMasaaki Ito, Takaki Hiwasa, Yoko Oshima, et al.
Asia-Pacific Journal of Clinical Oncology|July 7, 2021
Taxane-based versus platinum-based chemotherapy in early recurrent gastric cancer after radical surgery with S-1 adjuvant chemotherapy: A multi-institutional retrospective analysisSakae Nagaoka, Hiroharu Yamashita, Yasuyuki Seto, et al.
International Journal of Molecular Sciences|May 25, 2024
Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric CancerNatsuko Sasajima, Makoto Sumazaki, Yoko Oshima, et al.
Molecular and Clinical Oncology|July 14, 2022
Comparison between a new assay system, Elecsys<sup>®</sup> Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional studyTakashi Suzuki, Yoko Oshima, Fumiaki Shiratori, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|October 25, 2021
Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion ResearchNobuki Ishioka, Takashi Suzuki, Satoshi Yajima, et al.
Medicine International|March 6, 2023
The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinomaMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Molecular and Clinical Oncology|March 7, 2022
Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric CancerMasaaki Ito, Yusuke Oji, Mayuko Adachi, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Shock (Augusta, Ga.)|May 8, 2007
Inhibition of neutrophil elastase attenuates gut mucosal injury evoked by acute alveolar hypoxia in rabbitsNorihito Nakamura, Hiroshi Morisaki, Takeshi Suzuki, et al.
The American Journal of Case Reports|July 13, 2024
A Rare Case of Ileocecal Lymph Node Recurrence After Surgery in Siewert's Classification Type I Esophagogastric Junction AdenocarcinomaTakaatsu Bessho, Yasuyuki Miura, Satoshi Yajima, et al.
Surgery Today|November 19, 2013
Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a caseHideaki Shimada, Matsuo Nagata, Akihiro Cho, et al.
Molecular and Clinical Oncology|October 15, 2021
Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancersMasaaki Ito, Takaki Hiwasa, Yoko Oshima, et al.
Asia-Pacific Journal of Clinical Oncology|July 7, 2021
Taxane-based versus platinum-based chemotherapy in early recurrent gastric cancer after radical surgery with S-1 adjuvant chemotherapy: A multi-institutional retrospective analysisSakae Nagaoka, Hiroharu Yamashita, Yasuyuki Seto, et al.
International Journal of Molecular Sciences|May 25, 2024
Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric CancerNatsuko Sasajima, Makoto Sumazaki, Yoko Oshima, et al.
Molecular and Clinical Oncology|July 14, 2022
Comparison between a new assay system, Elecsys<sup>®</sup> Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional studyTakashi Suzuki, Yoko Oshima, Fumiaki Shiratori, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|October 25, 2021
Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion ResearchNobuki Ishioka, Takashi Suzuki, Satoshi Yajima, et al.
Medicine International|March 6, 2023
The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinomaMasaaki Ito, Satoshi Yajima, Takashi Suzuki, et al.
Molecular and Clinical Oncology|March 7, 2022
Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric CancerMasaaki Ito, Yusuke Oji, Mayuko Adachi, et al.
Pageof 8